Navigation Links
Craig Mundie Joins RainTree Oncology Board of Directors
Date:7/23/2014

SAN DIEGO, July 23, 2014 /PRNewswire/ -- RT Oncology Services Corporation today announced that Craig Mundie has agreed to join its board of directors. Mr. Mundie is currently senior advisor to the CEO of Microsoft Corporation, where he works on strategic projects within the company and on technology strategy and policy. Previously, he was Microsoft's chief research and strategy officer.

Mike Martin, president and chief executive officer of RainTree, said, "Craig is a visionary technology executive. His appointment is part of our ongoing expansion from a GPO into the premier data informatics platform for community oncologists. Through our new strategic partnership with Express Scripts and our growing suite of RainTree Analytics products, we are creating an automated National Oncology Medical Home that will enable better care at lower costs. Craig's talent and experience will be invaluable as we help to take patient care and practice performance in community oncology to the next level."

Bruce J. Gould, MD, chairman of the RainTree Advisory Board, said, "Craig's addition to the RainTree board of directors is great news for physicians and patients within the network. He will help to guide the creation of innovative technology infrastructure for RainTree's best-in-class analytics platform, which transforms clinical oncology data into actionable information. I firmly believe that, with Craig's expertise, these clinical support and practice management tools can revolutionize community oncology."

Mr. Mundie said, "Nowhere is innovation more vital than in the field of healthcare, and RainTree is doing ground-breaking work at the intersection of technology and oncology. The member network of community oncology practices will very shortly be able to leverage critically important data with the power to elevate the patient experience and, ultimately, improve outcomes. I am very excited to be joining the team."

Mr. Mundie has spent his career building startups in various fields, including supercomputing, consumer electronics, education, robotics and healthcare. As Microsoft's chief research and strategy officer, he oversaw Microsoft Research, one of the world's largest computer-science research organizations, and was responsible for Microsoft's long-term technology strategy, directing a number of technology incubations. Mr. Mundie has also served as Microsoft's chief technical officer for advanced strategies and policy. He joined Microsoft in 1992 to develop non-PC software platform technologies.

For more than a decade, Mr. Mundie has also been Microsoft's principal technology-policy liaison to the U.S. and foreign governments, with an emphasis on China, India and Russia. He has served on the U.S. National Security Telecommunications Advisory Committee and the Markle Foundation Task Force on National Security in the Information Age. In April 2009, Mr. Mundie was appointed by President Barack Obama to the President's Council of Advisors on Science and Technology.

About RainTree Oncology Services

RainTree Oncology Services is the nation's leading community oncology alliance, assisting its member practices in achieving better and more cost-effective treatment of oncology patients while creating new streams of revenue for community oncology practices. RainTree Oncology achieves this by negotiating and administering favorable GPO contracts; by implementing technology allowing RainTree Oncology members to develop and evaluate care pathways to improve patient care and outcomes while reducing costs to the healthcare system; and by developing commercial relationships that accelerate innovative oncology treatments and payer arrangements while optimizing oncology patient care and advancing the science of oncology. For more information, visit www.raintreeoncology.com or www.raintreeanalytics.com.

Contact

Phillip Bradley
Senior VP/General Counsel
RT Oncology Services Corporation
858-436-7462  


'/>"/>
SOURCE RT Oncology Services Corporation
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Uroplasty To Participate In The Craig-Hallum Alpha Select Conference
2. IRIDEX to Present at Craig-Hallum 4th Annual Alpha Select Conference
3. Cardica To Present At Craig-Hallum Alpha Select Conference
4. Ruggles Family Foundation and Mr. and Mrs. Rudy L. Ruggles, Jr. Make $1.25M Donation to J. Craig Venter Institute for New Study to Identify and Elucidate Healthy Aging Biomarkers
5. Craig Hospitals Patients With Brain And Spinal Cord Injuries Now Benefiting From Cutting-Edge Medical Records Exchange Technology
6. Depomed Announces Appointment of Vicente J. Anido, Jr., Ph.D. to Board of Directors, and Retirement of Directors Julian N. Stern and Craig R. Smith, M.D.
7. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
8. myMatrixx Names Craig Rollins, Vice President of Ancillary and Business Development
9. The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment
10. Elliott Sigal Joins NEA As Venture Partner And Senior Advisor
11. TIDI Products Joins aptitude LLC For Fast And Efficient Online Contracting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market by Manufacturers, ... and analysed the potential of Global Effective Microorganisms (EM) Market ... growth factors. The report identifies and analyses the emerging trends ... market. ... and Figures, 6 Major Company Profiles, spread across 124 pages ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
Breaking Medicine Technology:
(Date:4/29/2017)... Baltimore, MD (PRWEB) , ... April 29, 2017 , ... ... noisy jobs, so what are Americans doing in their leisure time that causes hearing ... assess lifestyle habits that may be contributing to hearing loss, as well as schedule ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... ... April 28, 2017 , ... Horizon Blue Cross Blue Shield ... credit rating of “A” and its outlook as “stable.” At the same time, the ... have fallen in recent years, dip below “capital adequacy” thresholds required for its strong ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... tubes . These lamps offer an instant energy-saving solution for F32T8 fluorescent lamps ... fixtures or disconnect ballasts. These 50,000 hour rated lamps utilize the existing electronic ...
(Date:4/28/2017)... Texas (PRWEB) , ... April 28, 2017 , ... The ... plaque in recently to the labor and delivery team at Women’s Hospital at Renaissance ... mothers who give birth at the hospital and decide to donate. , “Women’s ...
Breaking Medicine News(10 mins):